MET and neoplasm: Thus, overexpression of c-Met can be targeted by specific inhibitors (Maulik et al, 2002; Trusolino and Comoglio, 2002; Ma et al, 2003; Christensen et al, 2005), and immunohistochemically detected overexpression within tumour biopsies at the time of diagnosis may be relevant for patient management.